IF YOU LISTEN to podcasts of any sort, chances are you’ve heard tell of the magical properties of AG1, the moss-green powder formerly known as Athletic Greens—probably in the voice of a host whom you like and trust.
Joe Rogan swears by a morning glass of AG1 as “a science-backed solution for energy, focus, and high performance.” On The Pivot Podcast, journalist Kara Swisher tells listeners that a daily scoop can replace “a ton of other supplements like [a] daily multivitamin, minerals, and probiotics,” while her cohost, New York University professor Scott Galloway, shares that he takes his “with some yogurt and some coconut milk and a few berries.” The neuroscientist Andrew Huber- man on Huberman Lab says AG1 makes him “feel better” and contains “adaptogens to help buffer stress.” Over on New Heights, the chart-topping podcast hosted by Jason and Travis Kelce, the football-playing brothers claim the powder is the result of “a lot of testing” and should be the go-to product if you’re “serious about stepping up your health game.”
Mixed with cold water every morning, a 12-gram scoop of AG1’s $99-a-month supplement ($79 if you commit to a monthly subscription) promises to provide easily ingested “foundational nutrition” comprising “75 minerals, whole-food-sourced superfoods, probiotics, and adaptogens.” As a voice-over explains in one of the company’s sun-dappled video advertisements showing smiling athletic people shooting hoops, clim# trees, and cartwheeling through luscious green fields, AG1 is “here to make healthy habits beautifully easy.”
Esta historia es de la edición February - March 2025 de Fortune US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición February - March 2025 de Fortune US.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
The Blackstone Edge
90 DAYS. DOZENS OF INTERVIEWS. BILLIONS ON THE LINE. HOW BLACKSTONE'S CEO-MAKER GETS THE JOB DONE.
When Elon Musk has a really tough job, he turns to Steve Davis. DOGE might do the same.
IT WAS THE FALL OF 2022 when employees at Elon Musk's Boring Company began to notice Steve Davis wasn't around.
ASK ANDY - SHOULD MY STARTUP RAISE MONEY FROM VCS? IF SO, WHICH ONES DO I CHOOSE?
A FRIEND—I’ll call him Allen—spent years bootstrapping his real estate enterprise software company. After a long struggle to get to $1 million in sales, his business recently surged to $10 million, and revenue is now growing 100% year on year.
ELLIOTT HILL - JUST DOING IT
Staffers and brand loyalists cheered when Nike's new CEO came out of retirement to lead the company he has had an “irrational love” for since he began there as an intern. Turning it around will take more than good vibes.
HOW TO PLAN YOUR NEXT $100,000 VACATION
ON AN EXCURSION to the ancient city of Petra, Jordan, clients helicoptered in after-hours so they could tour the ruins alone.
THE BATTLE OVER AG1
Influencers are fighting over it. Scientists scoff at it. But the $100-a-month powder once known as Athletic Greens is only getting more popular.
THE WORKPLACE - GEN ZERS WANT TO BE THEIR OWN BOSS.CAN THE CORPORATE WORLD WOO THEM BACK?
CHASE GALLAGHER WAS 12 years old when he started mowing his neighbors' lawns in Chester County, Pa., for $35 a pop in the summer of 2013. At first the Gen Zer had only two customers, but thanks to some aggressive leafleting, he had 10 clients by the following year.
How much can DOGE do?
Elon Musk and Donald Trump aim to cut as much as $2 trillion in federal spending. It'll be even harder than it sounds.
YOUNG PEOPLE ARE DRINKING LESS ALCOHOL. CAN CEO MICHEL DOUKERIS PERSUADE THEM TO KEEP DRINKING AB INBEV'S BEERS?
SOME TIME AGO, top CEOs at an invitation-only seminar at Harvard Business School were asked to imagine the four crises they would likely confront during their tenure at the top: a health emergency, a geopolitical conflict, an economic downturn, and a trade war.
America's drug middlemen are now a $557 billion industry. Can Trump and his allies 'knock out' PBMs?
IN LATE DECEMBER, President-elect Donald Trump put pharmacy benefit managers, or PBMs, on notice.
